Status:
UNKNOWN
Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
Lead Sponsor:
OccuLogix
Conditions:
Macular Degeneration
Eligibility:
All Genders
50-85 years
Phase:
PHASE3
Brief Summary
AMD is a progressive disease of the retina which is nourished by a network of tiny blood vessels. There is evidence to suggest that the flow of nutrients to the retina is impaired in patients with AMD...
Eligibility Criteria
Inclusion
- Age 50-85
- Diagnosis of Dry AMD
- BCVA between 20/32 and 20/125 in at least one eye
- Numerous large plaques (soft drusen)
- No history of HIV, Hepatitis B or C
- Elevation of certain blood factors, such as total cholesterol, fibrinogen, and IgA
Exclusion
Key Trial Info
Start Date :
August 1 1999
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00078221
Start Date
August 1 1999
End Date
December 1 2005
Last Update
May 9 2008
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Retina Vitreous Associates
Beverly Hills, California, United States, 90211
2
Aran Eye Associates
Coral Gables, Florida, United States, 33134
3
Retina Health Care
Fort Myers, Florida, United States, 33901
4
UIC Eye Center
Chicago, Illinois, United States, 60612